Why vaccine makers aren't worried about Trump administration cuts
Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding declines by the Trump administration and a drop in biotech funding. That's what some of the top vaccine-maker executives told Yahoo …